title: Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment.
authors.forename: Z
authors.initials: Z
authors.lastname: Panossian
authors.forename: P L
authors.initials: PL
authors.lastname: Drury
authors.forename: T
authors.initials: T
authors.lastname: Cundy
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000075202:Contraindications; D048909:Diabetes Complications / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D016903:Drug Monitoring; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D028761:Withholding Treatment
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin; C517652:hemoglobin A1c protein, human
references.citation: Neth J Med. 2002 Jul;60(6):249-52
references.pmid: 12365468
references.citation: Nat Genet. 2011 Feb;43(2):117-20
references.pmid: 21186350
references.citation: Diabetes Care. 2011 Jun;34(6):1431-7
references.pmid: 21617112
references.citation: BMJ. 2007 Sep 8;335(7618):497
references.pmid: 17761999
references.citation: Lancet. 1998 Sep 12;352(9131):854-65
references.pmid: 9742977
references.citation: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD002967
references.pmid: 20393934
references.citation: Clin Pharmacokinet. 1996 May;30(5):359-71
references.pmid: 8743335
references.citation: J Nephrol. 2007 Sep-Oct;20(5):576-85
references.pmid: 17918143
references.citation: N Engl J Med. 1995 Aug 31;333(9):541-9
references.pmid: 7623902